Friday 6 November 2026 Export SOLV’s income statement to Excel — free account

Solventum Corporation

SOLV Healthcare Medical Instruments & Supplies

Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.

Revenue: −7.01%
EPS: −101.0%
Free cash flow: +561.9%
Total debt: −90.1%

Quarter to September 2026, against a year earlier

90.48 3.30 +3.79%

Follow SOLV

Alert me

Market cap: $14.8B
P/E: 102×
Fwd P/E: 47.7×
Dividend yield: —
F-score: 5/9
Altman Z: 2.22
Beneish M: −2.07
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Solventum Corporation 10-Q filed Nov 6, 2025

Fiscal Q3 2025 · Period ended Sep 30, 2025 · Filed Nov 6, 2025 · accepted 5:14 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors, against the 10-Q filed Aug 8, 2025: no comparison — incorporated by reference